Evidence-based data on pain relief with antidepressants

References

• Getto C J, Sorkness C A, Howell T. Issues in drug management. Part I. Antidepressants and chronic nonmalignant pain: a review. J Pain Symptom Manage 1987; 2: 9–18
   PubMedGoogle Scholar
• Orsulak P J, Waller D. Antidepressant drugs: additional clinical uses. Farn Pract 1989; 28: 209–16
   PubMed Web of Science ®Google Scholar
• Egbunike I G, Chaffee B J. Antidepressants in the management of chronic pain syndromes. Pharmacotherapy 1990; 10: 262–70
   PubMed Web of Science ®Google Scholar
• France R D. The future for antidepressants: treatment of pain. Psychopathology 1987; 20(Suppl 1)99–113
   PubMedGoogle Scholar
• France R D, Houpt J L, Ellinwood E H. Therapeutic effects of antidepressants in chronic pain. Gen Hosp Psychiatry 1984; 6: 55–63
   PubMed Web of Science ®Google Scholar
• Goodkin K, Gullion C M. Antidepressants for the relief of chronic pain: do they work. Ann Behav Med 1989; 11: 83–101
   Google Scholar
• Turner J A, Denny M C. Do antidepressant medications relieve chronic low back pain. Farn Pract 1993; 37: 545–53
   PubMed Web of Science ®Google Scholar
• McQuay H J, Moore R A, Eccleston C, Morley S, Williams A C. Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997; 1(6)1–135, i–iv
   Google Scholar
• Ongena P, Van Houdenhove B. Antidepressant-induced analgesia in chronic nonmalignant pain: a meta-analysis of 39 placebo-controlled studies. Pain 1992; 49: 205–19
   PubMed Web of Science ®Google Scholar
• Fishbain D A, Cutler R B, Rosomoff H L, Rosomoff R S. Do antidepressants have an analgesic effect in psychogenic pain and somatoform pain disorder: a meta-analysis. J Psychosomatic Med 1998; 60: 503–9
   PubMed Web of Science ®Google Scholar
• Philipp M, Fickinger M. Psychotropic drugs in the management of chronic pain syndromes. Phamacopsychiatry 1993; 26: 221–34
   PubMed Web of Science ®Google Scholar
• Goodkin K, Vrancken M AE, Feaser D. On the putative efficacy of the antidepressants in chronic, benign pain syndromes, an update. Pain Forum 1995; 4: 237–47
   Web of Science ®Google Scholar
• Max M B. Thirteen consecutive well-designed randomized trials show that antidepressants reduce pain in diabetic neuropathy and postherpetic neuralgia. Pain Forum 1995; 4: 248–53
   Web of Science ®Google Scholar
• Teasell R W, Merskey H, Deshpande S. Antidepressants in rehabilitation. Rehab Pharmacother 1999; 10: 237–53
   Google Scholar
• Stein D, Peri T, Edelstein E, Elizur A, Floman Y. The efficacy of amitriptyline and acetaminophen in the management of acute low back pain. Psychosomatics 1996; 37: 63–9
   PubMed Web of Science ®Google Scholar
• Levine J D, Gordon N C, Smith R, McBryde R. Desipramine enhances opiate postoperative analgesia. Pain 1986; 27: 45–9
   PubMed Web of Science ®Google Scholar
• Kerrick J M, Fine P G, Lipman A G, Love G. Low-dose amitriptyline as an adjunct to opioids for postoperative orthopedic pain: a placebo-controlled trial. Pain 1993; 52: 325–30
   PubMed Web of Science ®Google Scholar
• Tiengo M, Pagnoni B, Calmi A, Calza L, Rigoli M, Braga P, et al. Clomipramine compared with pentazocine as a unique treatment in postoperative pain. Int J Clin Pharmacol 1987; 7: 141–3
   Google Scholar
• Gordon N C, Heller P H, Gear R W, Levine J D. Interactions between fluoxetine and opiate analgesia for postoperative dental pain. Pain 1994; 58: 85–8
   PubMed Web of Science ®Google Scholar
• Cannon R O, Quyyumi A A, Mincemoyer R, Stine A M, Gracely R H, Smith W B, et al. Imipramine in patients with chests pain despite normal coronary angiograms. N Engl J Med 1994; 330: 1411–7
   PubMed Web of Science ®Google Scholar
• Hameroff S R, Cork R C, Scherer K, Crago R B, Neuman C, Womble J R, et al. Doxepin effects on chronic pain, depression and plasma opioids. J Clin Psychiatry 1982; 43: 22–7
   PubMed Web of Science ®Google Scholar
• Hameroff S R, Weiss J L, Lerman J C, Cork R C, Watts K S, Crago B R, et al. Doxepin's effect on chronic pain and depression: a controlled study. J Clin Psychiatry 1984; 45: 47–62
   PubMed Web of Science ®Google Scholar
• Hameroff S R, Weiss J L, Lerman J C, Cork R C, Watts K S, Crago B R, et al. Doxepin's effects on chronic pain and depression: a controlled study. J Clin Psychiatry 1984; 45: 47–53
   PubMed Web of Science ®Google Scholar
• Jenkins D G, Ebbutt A F, Evans C D. Tofranil in the treatment of low back pain. J Int Med Res 1976; 4: 28–40
   PubMed Web of Science ®Google Scholar
• Pheasant H, Bursk A, Goldfarb J, Azen S P, Weiss J N, Borelli L. Amitriptyline and chronic low back pain: a randomized double-blind crossover study. Spine 1983; 8: 552–7
   PubMed Web of Science ®Google Scholar
• Sternback R A, Janowsky D S, Huey L Y. Effects of altering brain serotonin activity on human chronic pain. Advances in pain research and therapy. Raven Press, New York, NY 1976; 1: 59–65
   Google Scholar
• Ward N G. Tricyclic antidepressants for chronic low-back pain. Mechanisms of action and prediction of response. Spine 1986; 11: 661–5
   PubMed Web of Science ®Google Scholar
• Ward N, Bokan J A, Phillips M, Benedetti C, Butler S, Spengler D. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared. J Clin Psychiatry 1984; 45: 54–7
   PubMed Web of Science ®Google Scholar
• Treves R, Montaine de la Roque P, Dumond J J, Bertin P, Arnaud M, Desproges-Gotteron R. Prospective study of the analgesic action of clomipramine versus placebo in refractory lumbosciatica (68 cases) (in French). Rev Rhum Mal Osteoartic 1991; 58: 549–52
   PubMedGoogle Scholar
• Atkinson J H, Slater M A, Williams R A, Zisook S, Patterson T L, Grant I, et al. A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998; 76: 287–96
   PubMed Web of Science ®Google Scholar
• Storch H, Steck P. Concomitant thymoleptic therapy in the frame of a controlled study with maprotiline (Ludiomil) in the treatment of back pain (in German). Nervenarzt 1982; 53: 445–50
   PubMedGoogle Scholar
• Atkinson J H, Slater M A, Wahlgren D R, Williams R A, Zisook S, Pruitt S D, et al. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999; 83: 137–45
   PubMed Web of Science ®Google Scholar
• Goodkin K, Gullion C M, Agras W S. A randomized, double-blind, placebo-controlled trial of trazodone hydrochloride in chronic low back pain syndrome. J Clin Psychopharmacol 1990; 10: 269–78
   PubMed Web of Science ®Google Scholar
• Couch S R, Hassanein R S. Amitriptyline in migraine prophylaxis. Arch Neurol 1979; 36: 695–9
   PubMed Web of Science ®Google Scholar
• Diamond S, Baltes B J. Chronic tension headaches: treated with amitriptyline - a double-blind study. Headache 1971; 11: 110–6
   PubMed Web of Science ®Google Scholar
• Indaco A, Carrieri P B. Amitriptyline in the treatment of headache in patients with Parkinson's disease: a double-blind placebo-controlled study. Neurology 1988; 28: 1720–2
   Google Scholar
• Lance J W, Curran D A. Treatment of chronic tension headache. Lancet 1964; 1: 1236–9
   PubMed Web of Science ®Google Scholar
• Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 1990; 30: 118–21
   PubMed Web of Science ®Google Scholar
• Langohr H D, Gerber W D, Koletzki E, Mayer K, Schroth G. Clomipramine and metoprolol in migraine prophylaxis: a double-blind crossover study. Headache 1985; 25: 107–13
   PubMed Web of Science ®Google Scholar
• Morland T J, Storli O V, Mogstad T E. Doxepin in the treatment of mixed vascular and tension headaches. Headache 1979; 19: 382–3
   PubMed Web of Science ®Google Scholar
• Noone J F. Clomipramine in the prevention of migraine. J Int Med Res 1980, Suppl 3: 49–52
   PubMedGoogle Scholar
• Ziegler D K, Hurwitz A, Hassanein R S, Kodanaz H A, Preskorn S G. Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol 1987; 44: 486–9
   PubMedGoogle Scholar
• Gobel H, Hamouz V, Hansen C, Heininger K, Hirsch S, Lidner V, et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994; 59: 241–9
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J. Neurol Neurosurg Psychiatry 1996; 61: 285–90
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Diener H C, Isler H, Meyer C, Scholz E, Taneri Z, et al. Effectiveness and tolerance of amitriptyline oxide in chronic tension headache: a multicenter double-blind study versus amitriptyline versus placebo (in German). Nervenarzt 1993; 64: 114–20
   PubMed Web of Science ®Google Scholar
• Ziegler D K, Hurwitz A., Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in prophylaxis of migraine. Pharmacokinetics and therapeutic effects. Arch Neurol 1993; 50: 825–30
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Diener H C, Isler H, Meyer C, Scholz E, Taneri Z, et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-center controlled study. Cephalalgia 1994; 14: 149–55
   PubMed Web of Science ®Google Scholar
• Poulsen D L, Hansen H J, Langemark M, Olesen J, Bech P. Discomfort or disability in patients with chronic pain syndrome. Psychother Psychosom 1987; 48: 60–2
   PubMed Web of Science ®Google Scholar
• Ward N G, Bloom V L, Friedel R O. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain 1979; 7: 331–41
   PubMed Web of Science ®Google Scholar
• Martucci N, Manna V, Porto C, Agnoli A. Migraine and the noradrenergic control of vasomotricity: a study with alpha-2 stimulant and alpha-2 blocker drugs. Headache 1985; 25: 95–100
   PubMed Web of Science ®Google Scholar
• Monro P, Swade C, Coppen A. Mianserin in the prophylaxis of migraine: a double-blind study. Acta Psychiat Scand Suppl 1985; 320: 98–103
   PubMedGoogle Scholar
• Sjaastad O. So-called ‘tension headache’ - the response to a 5–HT uptake inhibitor: femoxetine. Cephalalgia 1983; 3: 53–60
   PubMed Web of Science ®Google Scholar
• Saper J R, Silberstin S D, Lake A E, 3rd, Winters M E. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994; 34: 497–502
   PubMed Web of Science ®Google Scholar
• Steiner T J, Ahbme F, Findley L J, MacGregor E A, Wilkinson M. S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. Cephalalgia 1998; 18: 283–6
   PubMed Web of Science ®Google Scholar
• Battistella P A, Ruffilli R, Cernetti R, Pettenazzo A, Baldin L, Bertoli S, et al. A placebo-controlled crossover trial using trazodone in pediatric migraine. Headache 1993; 33: 36–9
   PubMed Web of Science ®Google Scholar
• Zeeberg I B, Orholm M, Nielsen J D, Honore P L, Larsen J JV. Femoxetine in the prophylaxis of migraine - a randomized comparison with placebo. Acta Neurol Scand 1981; 64: 452–9
   PubMed Web of Science ®Google Scholar
• Orholm M, Honoré P F, Zeeberg I. A randomized general practice group-comparative study of femoxetine and placebo in the prophylaxis of migraine. Acta Neurol Scand 1986; 74: 235–9
   PubMed Web of Science ®Google Scholar
• Kangasniemi P J, Nyrke T, Lang A H, Petersen E. Femoxetine - a new 5-HT uptake inhibitor - and prophylactic treatment of migraine. Acta Neurol Scand 1983; 68: 262–7
   PubMed Web of Science ®Google Scholar
• Adly C, Straumanis J, Chesson A. Fluoxetine prophylaxis of migraine. Headache 1992; 32: 101–4
   PubMed Web of Science ®Google Scholar
• Manna V, Bolino F, DiCicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 1994; 34: 44–9
   PubMed Web of Science ®Google Scholar
• Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985; 25: 273–5
   PubMed Web of Science ®Google Scholar
• Engel C C, Jr, Walker E A, Engel A L, Bullis J, Armstrong A. A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain. J Psychosom Res 1998; 44: 203–7
   PubMed Web of Science ®Google Scholar
• Fiorentino M. Controlled trial of imipramine as an analgesic in oncology (in Italian). Rivista Med Trentina 1967; 4: 387–97
   Google Scholar
• Walsh T D. Controlled study of imipramine (IM) and morphine (M) in chronic pain due to advanced cancer. Proceedings of the American Society of Clinical Oncology Annual Meeting 1986. ASCO, Alexandria, VA 1986; 237
   Google Scholar
• Frank R G, Kashani J H, Parker J C, Beck N C, Brownlee-Duffeck M, Elliott T R, et al. Antidepressant analgesia in rheumatoid arthritis. J Rheumatol 1988; 15: 1632–8
   PubMed Web of Science ®Google Scholar
• Ganvir P, Beaumont G, Seldrup J. A comparative trial of clomipramine and placebo as adjunctive therapy in arthralgia. J Int Med Res 1980; 8(Suppl 3)60–6
   PubMedGoogle Scholar
• Glick E N, Fowler P D. Imipramine in chronic arthritis. Pharm Med 1979; 1: 94–6
   Google Scholar
• Grace E M, Bellamy N, Kassam Y, Buchanan W W. Controlled double-blind, randomized trial of amitriptyline in relieving articular pain and tenderness in patients with rheumatoid arthritis. Curr Med Res Opin 1985; 9: 426–9
   PubMed Web of Science ®Google Scholar
• Macfarlane J G, Jalali S, Grace E M. Trimipramine in rheumatoid arthritis: a randomized double-blind trial in relieving pain and joint tenderness. Curr Med Res Opin 1986; 10: 89–93
   PubMed Web of Science ®Google Scholar
• McDonald-Scott W A. The relief of pain with an anti-depressant in arthritis. Practitioner 1969; 202: 802–7
   PubMedGoogle Scholar
• MacNeill A L, Dick W C. Trimipramine and rheumatoid factor. J Int Med Res 1976; 4(Suppl 2)23–7
   PubMedGoogle Scholar
• Rani P U, Naidu M UR, Prasad V BN, Rao T RK, Shobha J C. An evaluation of antidepressants in rheumatic pain conditions. Anesth Analg 1996; 83: 371–5
   PubMed Web of Science ®Google Scholar
• Singh A N, Saxena B, Gent M, Nelson H L. Maprotiline (Ludiomil, Ciba 34, 276-BA) and imipramine in depressed outpatients: a double-blind clinical study. Curr They Res Clin Exper 1976; 19: 451–62
   PubMed Web of Science ®Google Scholar
• Rani P U, Naidu M UR, Prasad V BN, Rao T RK, Shobha J C. An evaluation of antidepressants in rheumatic pain conditions. Anesth Analg 1996; 83: 371–5
   PubMed Web of Science ®Google Scholar
• Wheatly D. Antidepressants in elderly arthritis. Practitioner 1986; 230: 477–81
   PubMedGoogle Scholar
• Caruso I, Pietrogrande V. Italian double-blind multicenter study comparing S-adenosylmethionine, naproxen, and placebo in the treatment of degenerative joint disease. Am J Med 1987; 83(Suppl 5A)66–71
   PubMed Web of Science ®Google Scholar
• Gringas M. A clinical trial of tofranil in rheumatic pain in general practice. J Int Med Res 1976; 4: 41–9
   PubMed Web of Science ®Google Scholar
• Carette S, McCain G A, Bell D A, Fam A G. Evaluation of amitriptyline in primary fibrositis: a double blind, placebo controlled study. Arthritis Rheum 1986; 29: 655–9
   PubMed Web of Science ®Google Scholar
• Goldenberg D L, Felson D T, Dinerman H. A randomized controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–7
   PubMed Web of Science ®Google Scholar
• Scudds R A, McCain G A, Rollman G B, Harth M. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; 16: 98–105
   Google Scholar
• Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P. A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol 1998; 37: 1279–86
   PubMedGoogle Scholar
• Goldenberg D, Mayskiy M, Mossey C, Ruthazer R, Schmid C. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996; 39: 1852–9
   PubMed Web of Science ®Google Scholar
• Carette S, Bell M J, Reynolds W J, Haraoui B, McCain G A, Bykerk V P, et al. Comparison of amitriptyline, cyclo-benzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37: 32–40
   PubMed Web of Science ®Google Scholar
• Bennett R M, Gatter R A, Campbel S M, Andrews R P, Clark S R, Scarola J A. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum 1988; 31: 153542
   Google Scholar
• Kempenaers C H, Simenon G, Vander Elst M, Fransolet L, Mingard P, deMaertelaer V, et al. Effect of an anti-diencephalon immune serum on pain and sleep in primary fibromyalgia. Neuropsychobiology 1994; 30: 66–72
   PubMed Web of Science ®Google Scholar
• Ginsberg F, Mancaux A, Joos E, Vanhove, Famacy J P. A randomized placebo-controlled trial of sustained-release amitriptyline in primary fibromyalgia. J Musculo Pain 1996; 14: 37–47
   Google Scholar
• Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 1995; 61: 445–59
   PubMed Web of Science ®Google Scholar
• Wolfe F, Cathey M A, Hawley D J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheum 1994; 23: 255–9
   PubMed Web of Science ®Google Scholar
• Tavoni A, Vitali C, Bombardieri S, Pasero G. Evaluation of S-adenasyl-methionine in primary fibromyalgia: a double-blind crossover study. Am J Med 1987; 83(Suppl 5A)107–10
   PubMed Web of Science ®Google Scholar
• Sharav Y, Singer E, Schmidt E, Dionne R A, Dubner R. The analgesic effect of amitriptyline on chronic facial pain. Pain 1987; 31: 199–209
   PubMed Web of Science ®Google Scholar
• Harrison S D, Glover L, Feinmann C, Pearce S A, Harris M. A comparison of antidepressant medication alone and in conjunction with cognitive behavioral therapy for chronic idiopathic facial pain. Progr Pain Res Manage 1997; 8: 663–71
   Google Scholar
• Berstad A, Bjerke K, Carlsen E, Aadland E. Treatment of duodenal ulcer with antacids in combination with trimipramine or cimetidine. Scand J Gastroenterol Suppl 1980; 58: 46–51
   PubMedGoogle Scholar
• Guldahl M. The effect of trimipramine (Surmontil) on masked depression in patients with duodenal ulcer. Scand J Gastroenterol 1977, Suppl 43: 27–31
   PubMedGoogle Scholar
• Nitter L, Jr, Haraldsson A, Holck P, Hoy C, Munthe-Kaas J, Myrhol P, et al. The effect of trimipramine on the healing of peptic ulcer. A double-blind study. Multicentre investigation -G.P. Scand J Gastroenterol Suppl 1977; 43: 39–45
   PubMedGoogle Scholar
• Wetterhus S, Auben E, Berg C E. The effect of trimipramine on symptoms and healing of peptic ulcer. Scand J Gastroenterol Suppl 1977; 43: 33–8
   PubMedGoogle Scholar
• Moshal M G, Khan F T. Trimipramine in the treatment of active duodenal ulceration. Scan J Gastroenterol 1981; 16: 195–298
   Web of Science ®Google Scholar
• Shrivastava R K, Siegal H, Lawlor R, Shah B K, Dayican G. Doxepin therapy for duodenal ulcer: a controlled trial in patients who failed to respond to cimetidine. Clin Ther 1985; 7: 319–26
   PubMed Web of Science ®Google Scholar
• Anderson O K, Bergsaker-Aspoy J, Halvorsen L, Giercksky K E. Doxepin in the treatment of duodenal ulcer. A double-blind clinical study comparing doxepin and placebo. Scan J Gastroenterol 1984; 19: 923–5
   PubMed Web of Science ®Google Scholar
• Don G J, Shearman D J, Hecker R. Double-blind trial of trimipramine in the treatment of duodenal ulcer. Med J Aust 1980; 2: 567–8
   PubMed Web of Science ®Google Scholar
• Greenbaum D S, Mayle J E, Vanegeren L E, Jerome J A, Mayor J W, Greenbaum R B, et al. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig. Dis Sci 1987; 32: 257–66
   PubMed Web of Science ®Google Scholar
• Rajagopalan M, Kurian G, John J. Symptom relief with amitriptyline in the irritable bowel syndrome. J Gastroenterol Hepatol 1998; 13: 73841
   Web of Science ®Google Scholar
• Gourlay G K, Cherry D A, Cousins M J, Love B L, Graham J R, McLachlan M O. A controlled study of a serotonin reuptake blocker, zimelidine, in the treatment of chronic pain. Pain 1987; 25: 35–52
   Web of Science ®Google Scholar
• Johansson F, Von Knorring L. A double-blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain 1979; 7: 69–78
   PubMed Web of Science ®Google Scholar
• McQuay H J, Carroll D, Glynn C J. Low dose amitriptyline in the treatment of chronic pain. Anaesthesia 1992; 47: 646–52
   PubMed Web of Science ®Google Scholar
• Pilowsky I, Hallett E C, Bassett D L, Thomas P G, Penhall R K. A controlled study of amitriptyline in the treatment of chronic pain. Pain 1982; 14: 169–79
   PubMed Web of Science ®Google Scholar
• Zitman F G, Linssen A CG, Edelbroek P M, Stijnen T. Low dose amitriptyline in chronic pain: the gain is modest. Pain 1990; 42: 3542
   Web of Science ®Google Scholar
• Evans W, Gender F, Blackwell B, Galbrecht C. The effects of antidepressant drugs on pain relief and mood in the chronically ill. A double-blind study. Psychosomatics 1973; 14: 214–9
   PubMed Web of Science ®Google Scholar
• Raft D, Davidson J, Wasik J, Mattox A. Relationship between response to phenelzine and MAO inhibition in a clinical trial of phenelzine, amitriptyline and placebo. Neuropsychobiology 1981; 7: 122–6
   PubMed Web of Science ®Google Scholar
• McQuay H J, Tramer M, Nye B A, Carroll D, Wiffen P J, Moore R A. A systematic review of antidepressants in neuropathic pain. Pain 1996; 68: 217–27
   PubMed Web of Science ®Google Scholar
• Rascol O, Tran M A, Bonnevialle P, Belin J, Cotonat J, Guiraud-Chaumeil B, et al. Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin. Clin Neuropharmacol 1987; 10: 560–4
   PubMed Web of Science ®Google Scholar
• Watson C PN, Smythe I E. Therapeutic window for amitriptyline analgesia. CMAJ 1984; 130: 105
   PubMed Web of Science ®Google Scholar
• Edelbroek P M, Linssen C G, Zitman F G, Rooymans H GM, de Wolff F A. Analgesic and antidepressive effects of low-dose amitriptyline in relation to its metabolism in patients with chronic pain. Clin Pharmacol Ther 1986; 39: 156–61
   PubMed Web of Science ®Google Scholar
• Montastruc J L, Tran M A, Charlet J P, Gaillard-Plaza G, David J, Cotonat J, et al. Analgesic properties and plasma concentrations of clomipramine in chronic pain. Revue Neurologique 1983; 139: 583–7
   PubMed Web of Science ®Google Scholar
• Guiol C, Tran M A, Blac M, Charlet J P, Eschalier A, Cotonat J, et al. Is there any relationship between antinociception, doses and plasma levels of clomipramine during subchronic treatment in rats. Biomed Pharmacother 1984; 38: 59–62
   PubMed Web of Science ®Google Scholar
• Brenne E, van der Hagen K, Maehlum E, Husebo S. Treatment chronic pain with amitriptyline. A double-blind dosage study with determination of serum levels (in Norwegian). Tidsskr Nor Laegeforen 1997; 117: 3491–4
   PubMedGoogle Scholar
• Fishbain D A, Cutler R B, Rosomoff H L, Steele-Rosomoff R. What is the quality of the implemented meta-analytic procedures in chronic pain treatment meta-analyses. Clin J Pain 2000; 16: 73–85
   PubMed Web of Science ®Google Scholar
• Woolf C J, Mannion R J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999; 353: 1959–64
   PubMed Web of Science ®Google Scholar
• Fishbain D A, Rosomoff H L, Goldberg M, Cutler R, Abdel-Moty E, Khalil T M, et al. The prediction of return to the workplace after multidisciplinary pain center treatment. Clin J Pain 1993; 9: 3–15
   PubMed Web of Science ®Google Scholar
• Wells K B. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. Am J Psychiatry 1999; 156: 5–10
   PubMed Web of Science ®Google Scholar
• Verhaak P FM, Kerssens J J, Dekker J, Sorbi M J, Bensing J M. Prevalance of chronic benign disorder among adults: a review of the literature. Pain 1998; 77: 231–9
   PubMed Web of Science ®Google Scholar
• Goodkin K, Feaster D J. Meta-analysis and the need for study quality control. Pain Forum 1998; 7: 904
   Web of Science ®Google Scholar
• Olkin I. Quality and diagnostics in meta-analysis. Pain Forum 1998; 7: 95–7
   Web of Science ®Google Scholar